Explore Real Clinical Cases

Explore real cases with stories and pictures

Explore Our On-Line Learning Content

Enhance your knowledge of tumors and their management

Hodgkin's Lymphoma of the Bone

Summary

Bony involvement of Hodgkin’s disease (HD) is between 9.2% - 30.3% of patients. Osseous lesions are most commonly due to hematogenous dissemination in stage IV disease or due to direct invasion from an adjacent lymph node leading to focal sclerosis.

Usually pain is the presenting symptom in primary bone disease. Weight loss and malaise may be absent.
Complete Information on this Tumor
Introduction and Definition: 

Bony involvement of Hodgkin’s disease (HD) is between 9.2% - 30.3% of patients. Bone marrow involvement in late stages of HD usually does not produce destructive bone lesions. Primary bone involvement of HD is particularly rare, occurring in less than 1%. Osseous lesions are most commonly due to hematogenous dissemination in stage IV disease or due to direct invasion from an adjacent lymph node leading to focal sclerosis. Primary bone involvement is thought to arise "de novo" within marrow, resulting in cortical erosion and lysis.

Symptoms and Presentation: 

Usually pain is the presenting symptom in primary bone disease. Weight loss and malaise may be absent. Lytic lesions are most common, but mixed or sclerotic lesions can also be seen. Lesions may be associated with a periosteal reaction. Bone scintigraphy is useful in detection of skeletal HD. MRI is very sensitive in the localization of subtle marrow disease. Marrow involvement produces a hypointense signal on T1 weighted spin echo sequences and high signal on T2 weighted gradient echo sequences.

Preferred Biopsy Technique for this Tumor: 
Small biopsy specimens are usually not diagnostic. Paget’s disease, metastatic tumors, chronic osteomyelitis, eosinophilic granuloma, and primary sarcoma are among the histological differentials.
Treatment Options for this Tumor: 
The prognosis in stage Ie is similar to that of local nodal disease without osseous involvement. Patients with one or multiple bone lesions usually respond well to combined modality treatment, including chemotherapy and local radiotherapy. Surgery should be considered for lesions that present a risk of pathological fracture.